← Back to Clinical Trials
Recruiting NCT04613791

NCT04613791 Situation and Evolution of the Misuse of Alcohol and Other Addictive Behaviors in Obese Patients Being Managed at Nîmes University Hospital

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04613791
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Nīmes
Condition Obesity
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2021-02-16
Primary Completion 2026-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Blood test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 800 participants in total. It began in 2021-02-16 with a primary completion date of 2026-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Obesity is a multifactorial pathology in which external (lifestyle, environment) and internal (psychological or biological, especially genetic) factors are involved. These are responsible for a positive energy balance. One of the external factors that can intervene in the genesis of obesity is the existence of eating disorders: bulimic hyperphagia. Some teams consider bulimic hyperphagia as a form of addiction. After bariatric surgery, the appearance of new addictions has been observed. In connection with Pr Perney's addictology department, the investigators have observed that some patients under treatment for obesity at the endocrinology department subsequently developed other addictions, in particular misuse of alcohol. The hypotheses of this research are : There appears to be a transfer from eating disorders to substance misuse addiction in post-treatment of obesity, particularly in patients who have undergone bariatric surgery. The misuse of addictive substances most concerned by this transfer of addiction in the post-treatment of obesity, particularly after bariatric surgery, seems to be the misuse of alcohol. This will be the first French cohort study on addictive behaviors in patients undergoing bariatric surgery and the first international study including non-operated obese patients benefiting from medical care alone. This study will improve the multidisciplinary management of these patients by integrating addictologists.

Eligibility Criteria

* Patient being managed for the first time at Nîmes University Hospital Obesity Clinic ( complete hospitalization, outpatients' or consultation). * Patient being managed for obesity defined by a body mass index (BMI) of 30 kg.m-² or over * Patient affiliated to or covered by a health insurance scheme. * Adult patient (≥ 18 years). Exclusion Criteria: * Patient with psychiatric disorder reducing capacity for comprehension. * Patient in an exclusion period determined by another study. * Patient under legal guardianship, tutorship or curatorship. * Patient to whom it is impossible to give clear information * Patient who is pregnant, about to give birth or breastfeeding.

Contact & Investigator

Central Contact

Emma LUCQUIAUD, Dr.

✉ emma.lucquiaud@chu-nimes.fr

📞 +33 4.66.68.33.21

Frequently Asked Questions

Who can join the NCT04613791 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04613791 currently recruiting?

Yes, NCT04613791 is actively recruiting participants. Contact the research team at emma.lucquiaud@chu-nimes.fr for enrollment information.

Where is the NCT04613791 trial being conducted?

This trial is being conducted at Nîmes, France.

Who is sponsoring the NCT04613791 clinical trial?

NCT04613791 is sponsored by Centre Hospitalier Universitaire de Nīmes. The trial plans to enroll 800 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology